Universe Pharmaceuticals INC (UPC)
NASDAQ: UPC · Real-Time Price · USD
5.13
+0.21 (4.18%)
Oct 28, 2025, 4:00 PM EDT - Market closed
UPC Revenue
Universe Pharmaceuticals INC had revenue of $9.15M in the half year ending March 31, 2025, a decrease of -50.44%. This brings the company's revenue in the last twelve months to $19.29M, down -27.81% year-over-year. In the fiscal year ending September 30, 2024, Universe Pharmaceuticals INC had annual revenue of $23.02M, down -28.74%.
Revenue (ttm)
$19.29M
Revenue Growth
-27.81%
P/S Ratio
0.05
Revenue / Employee
$85,747
Employees
225
Market Cap
2.89M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 23.02M | -9.28M | -28.74% |
| Sep 30, 2023 | 32.31M | -7.83M | -19.52% |
| Sep 30, 2022 | 40.14M | -7.84M | -16.34% |
| Sep 30, 2021 | 47.98M | 17.28M | 56.27% |
| Sep 30, 2020 | 30.70M | -2.53M | -7.60% |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
UPC News
- 7 months ago - Universe Pharmaceuticals INC Announces Share Consolidation - GlobeNewsWire
- 8 months ago - Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report - GlobeNewsWire
- 9 months ago - Universe Pharmaceuticals INC Receives Nasdaq Delisting Notice Subject to Hearing Request - GlobeNewsWire
- 11 months ago - Univest Securities, LLC Announces Closing of $15 Million Registered Direct Offering for its Client Universe Pharmaceuticals INC (NASDAQ: UPC) - GlobeNewsWire
- 1 year ago - Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency - GlobeNewsWire
- 1 year ago - Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2024 - GlobeNewsWire
- 1 year ago - Universe Pharmaceuticals INC Reports Fiscal Year 2023 Financial Results - PRNewsWire
- 2 years ago - Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares - GlobeNewsWire